[开放获取]   长波紫外线1皮肤科临床应用专家共识（2022）

doi:10.35541/cjd.20220423

Abstract

Abstract: 【Abstract】 Ultraviolet A1 （UVA1） has been proven to be useful in the treatment of a lot of dermatoses. UVA1 not only has stronger penetrativity than ultraviolet B （UVB） does, but also has no adverse effects such as phototoxic reactions compared with psoralen plus ultraviolet A radiation （PUVA）, which provides a new therapy for localized scleroderma, atopic dermatitis, mycosis fungoides, etc. In order to ensure the efficacy and safety of UVA1 phototherapy, relevant experts developed this consensus after full discussions based on clinical research data and experience. The consensus elaborates on the spectral characteristics, mechanisms of action, indications and contraindications, treatment regimens of, as well as adverse reactions induced by UVA1 phototherapy, providing guidance for dermatologists in clinical practice.

Key words: Ultraviolet therapy, Skin diseases, Therapeutic uses, Scleroderma, localized, Dermatitis, atopic, Mycosis fungoides, UVA1, Expert consensus

Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Clinical application of ultraviolet A1 in dermatology: an expert consensus statement （2022）[J]. Chinese Journal of Dermatology, 2022, 55(11): 956-961.doi:10.35541/cjd.20220423

References ［61］

［1］	Krutmann J, Czech W, Diepgen T, et al. High⁃dose UVA1 therapy in the treatment of patients with atopic dermatitis［J］. J Am Acad Dermatol, 1992,26（2 Pt 1）:225⁃230. doi: 10.1016/0190⁃9622（92）70031⁃a.
［2］	Masuda H, Morita A. Ultraviolet A1 phototherapy utilizing ultraviolet light⁃emitting diodes and a short wavelength cutoff filter［J］. J Dermatol Sci, 2021,101（2）:138⁃140. doi: 10.1016/j.jdermsci.2020.11.004.
［3］	Gambichler T, Terras S, Kreuter A. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies［J］. Clin Dermatol, 2013,31（4）:438⁃454. doi: 10.1016/j.clindermatol.2013.01.011.
［4］	Shunko A. Inada. Development of an ultraviolet A1 light emitting diode⁃based device for phototherapy［J］. Open Dermatol J, 2012, 6:13⁃24. doi: 10.2174/1874372201206010013.
［5］	Wan P, Edwards C, Zheng J, et al. Validation of a novel high⁃intensity LED light source for skin phototesting at 365 nm［J］. Photodermatol Photoimmunol Photomed, 2012,28（2）:80⁃83. doi: 10.1111/j.1600⁃0781.2011.00641.x.
［6］	Gambichler T, Skrygan M, Tomi NS, et al. Differential expression of decorin in localized scleroderma following ultraviolet⁃A1 irradiation［J］. J Am Acad Dermatol, 2007,56（6）:956⁃959. doi: 10.1016/j.jaad.2006.10.961.
［7］	Stege H, Berneburg M, Humke S, et al. High⁃dose UVA1 radiation therapy for localized scleroderma［J］. J Am Acad Dermatol, 1997,36（6 Pt 1）:938⁃944. doi: 10.1016/s0190⁃9622（97）80277⁃0.
［8］	鞠梅, 张青松, 张小华, 等. 不同剂量UVA1辐射硬皮病鼠模型的研究［J］. 中华皮肤科杂志, 2009,42（1）:8⁃11. doi: 10. 3760/cma.j.issn.0412⁃4030.2009.01.004.
［9］	鞠梅, 陈崑, 常宝珠, 等. 不同剂量UVA1辐射对硬皮病鼠模型皮肤匀浆CD34和M30的影响［J］. 中华皮肤科杂志, 2011,44（3）:178⁃181. doi: 10.3760/cma.j.issn.0412⁃4030.2011.03.009.
［10］	Skov L, Hansen H, Allen M, et al. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor⁃alpha in human skin［J］. Br J Dermatol, 1998,138（2）:216⁃220. doi: 10.1046/j.1365⁃2133.1998.02063.x.
［11］	Trompezinski S, Pernet I, Mayoux C, et al. Transforming growth factor⁃beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin⁃1 in human dermal fibroblasts［J］. Br J Dermatol, 2000,143（3）:539⁃545. doi: 10.1111/j.1365⁃2133.2000.03707.x.
［12］	Godar DE. UVA1 radiation triggers two different final apoptotic pathways［J］. J Invest Dermatol, 1999,112（1）:3⁃12. doi: 10.1046/ j.1523⁃1747.1999.00474.x.
［13］	Walker D, Jacobe H. Phototherapy in the age of biologics［J］. Semin Cutan Med Surg, 2011,30（4）:190⁃198. doi: 10.1016/j.sder.2011.08.004.
［14］	Zandi S, Kalia S, Lui H. UVA1 phototherapy: a concise and practical review［J］. Skin Therapy Lett, 2012,17（1）:1⁃4.
［15］	Barros NM, Sbroglio LL, Buffara MO, et al. Phototherapy［J］. An Bras Dermatol, 2021,96（4）:397⁃407. doi: 10.1016/j.abd.2021. 03.001.
［16］	Tuchinda C, Kerr HA, Taylor CR, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States［J］. Photodermatol Photoimmunol Photomed, 2006,22（5）:247⁃253. doi: 10.1111/j.1600⁃0781.2006.00245.x.
［17］	Zhou J, Yi X, Li Y, et al. Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis［J］. Lasers Med Sci, 2018,33（9）:1979⁃1982. doi: 10.1007/s10103⁃018⁃2564⁃z.
［18］	Totonchy MB, Chiu MW. UV⁃based therapy［J］. Dermatol Clin, 2014,32（3）:399⁃413, ix⁃x. doi: 10.1016/j.det.2014.03.003.
［19］	Andres C, Kollmar A, Mempel M, et al. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study［J］. Br J Dermatol, 2010,162（2）:445⁃447. doi: 10.1111/j.1365⁃2133.2009.09438.x.
［20］	Sator PG, Radakovic S, Schulmeister K, et al. Medium⁃dose is more effective than low⁃dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20⁃MHz ultrasound assessment［J］. J Am Acad Dermatol, 2009,60（5）:786⁃791. doi: 10.1016/j.jaad.2008.12.013.
［21］	Kreuter A, Hyun J, Stücker M, et al. A randomized controlled study of low⁃dose UVA1, medium⁃dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma［J］. J Am Acad Dermatol, 2006,54（3）:440⁃447. doi: 10.1016/j.jaad.2005.11.1063.
［22］	Abeck D, Schmidt T, Fesq H, et al. Long⁃term efficacy of medium⁃dose UVA1 phototherapy in atopic dermatitis［J］. J Am Acad Dermatol, 2000,42（2 Pt 1）:254⁃257. doi: 10.1016/S0190⁃9622（00）90134⁃8.
［23］	Pacifico A, Iacovelli P, Damiani G, et al. ′High dose′ vs. ′medium dose′ UVA1 phototherapy in italian patients with severe atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 2019,33（4）:718⁃724. doi: 10.1111/jdv.15362.
［24］	Trovato E, Pellegrino M, Filippi F, et al. Clinical and histological evaluation in patients with mycosis fungoides treated with UVA1［J］. G Ital Dermatol Venereol, 2020,155（3）:306⁃311. doi: 10.23736/S0392⁃0488.18.05867⁃4.
［25］	Su LN, Ren J, Cheng SM, et al. UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study［J］. Lasers Med Sci, 2017,32（8）:1819⁃1823. doi: 10.1007/s10103⁃017⁃2280⁃0.
［26］	El⁃Mofty M, Mostafa W, Youssef R, et al. Ultraviolet A in vitiligo［J］. Photodermatol Photoimmunol Photomed, 2006,22（4）:214⁃216. doi: 10.1111/j.1600⁃0781.2006.00229.x.
［27］	Lotti T, Tchernev G, Wollina U, et al. Successful treatment with UVA 1 laser of non ⁃ responder vitiligo patients［J］. Open Access Maced J Med Sci, 2018,6（1）:43⁃45. doi: 10.3889/oamjms.2018.047.
［28］	Petering H, Breuer C, Herbst R, et al. Comparison of localized high⁃dose UVA1 irradiation versus topical cream psoralen⁃UVA for treatment of chronic vesicular dyshidrotic eczema［J］. J Am Acad Dermatol, 2004,50（1）:68⁃72. doi: 10.1016/s0190⁃9622（03）00782⁃5.
［29］	Polderman MC, Govaert JC, le Cessie S, et al. A double⁃blind placebo⁃controlled trial of UVA⁃1 in the treatment of dyshidrotic eczema［J］. Clin Exp Dermatol, 2003,28（6）:584⁃587. doi: 10. 1046/j.1365⁃2230.2003.01378.x.
［30］	Gambichler T, Hyun J, Sommer A, et al. A randomised controlled trial on photo（chemo）therapy of subacute prurigo［J］. Clin Exp Dermatol, 2006,31（3）:348⁃353. doi: 10.1111/j.1365⁃2230.2006.02081.x.
［31］	Gobello T, Mazzanti C, Sordi D, et al. Medium⁃ versus high⁃dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study［J］. J Am Acad Dermatol, 2003,49（4）:679⁃684. doi: 10.1067/s0190⁃9622（03）01483⁃x.
［32］	Lim SH, Kim SM, Oh BH, et al. Low⁃dose ultraviolet A1 phototherapy for treating pityriasis rosea［J］. Ann Dermatol, 2009,21（3）:230⁃236. doi: 10.5021/ad.2009.21.3.230.
［33］	Gambichler T, Schmitz L. Ultraviolet A1 phototherapy for fibrosing conditions［J］. Front Med （Lausanne）, 2018,5:237. doi: 10.3389/fmed.2018.00237.
［34］	Herz⁃Ruelas ME, Gomez⁃Flores M, Miranda⁃Maldonado I, et al. Escalating dosimetry of UVA⁃1 in the treatment of alopecia areata［J］. Int J Dermatol, 2017,56（6）:653⁃659. doi: 10.1111/ijd.13572.
［35］	Herz⁃Ruelas ME, Welsh O, Gomez⁃Flores M, et al. Ultraviolet A⁃1 phototherapy as an alternative for resistant alopecia areata［J］. Int J Dermatol, 2015,54（10）:e445⁃e447. doi: 10.1111/ijd.13054.
［36］	Kreuter A, Breuckmann F, Uhle A, et al. Low⁃dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis［J］. J Am Acad Dermatol, 2004,50（5）:740⁃747. doi: 10.1016/j.jaad. 2003.08.026.
［37］	Polat M, Kaya H, Şahin A. A new approach in the treatment of keloids: UVA⁃1 laser［J］. Photomed Laser Surg, 2016,34（3）:130⁃133. doi: 10.1089/pho.2015.4046.
［38］	Eberlein⁃König B, Vogel M, Katzer K, et al. Successful UVA1 phototherapy in a patient with scleredema adultorum［J］. J Eur Acad Dermatol Venereol, 2005,19（2）:203⁃204. doi: 10.1111/j. 1468⁃3083.2005.00935.x.
［39］	Mertens JS, Seyger M, Thurlings RM, et al. Morphea and eosinophilic fasciitis: an update［J］. Am J Clin Dermatol, 2017,18（4）:491⁃512. doi: 10.1007/s40257⁃017⁃0269⁃x.
［40］	Schaller M, Romiti R, Wollenberg A, et al. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy［J］. J Am Acad Dermatol, 2001,45（6）:969⁃970. doi: 10.1067/mjd.2001.117248.
［41］	Joshi TP, Duvic M. Granuloma annulare: an updated review of epidemiology, pathogenesis, and treatment options［J］. Am J Clin Dermatol, 2022,23（1）:37⁃50. doi: 10.1007/s40257⁃021⁃00636⁃1.
［42］	Feily A, Yaghoobi R, Nilforoushzadeh MA. Treatment modalities of palmoplantar lichen planus: a brief review［J］. Postepy Dermatol Alergol, 2016,33（6）:411⁃415. doi: 10.5114/ada.2016. 63879.
［43］	Grundmann⁃Kollmann M, Behrens S, Gruss C, et al. Chronic sclerodermic graft⁃versus⁃host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy［J］. J Am Acad Dermatol, 2000,42（1 Pt 1）:134⁃136. doi: 10. 1016/s0190⁃9622（00）90023⁃9.
［44］	Knobler R, Moinzadeh P, Hunzelmann N, et al. European Dermatology Forum S1⁃guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes［J］. J Eur Acad Dermatol Venereol, 2017,31（9）:1401⁃1424. doi: 10.1111/jdv. 14458.
［45］	黄茂芳, 田歆, 罗育武, 等. 中剂量UVA1光疗对11例斑块状硬皮病的临床疗效观察［J］. 皮肤性病诊疗学杂志, 2015,（2）:109⁃111. doi: 10.3969/j.issn.1674⁃8468.2015.02.007.
［46］	Gambichler T, Othlinghaus N, Tomi NS, et al. Medium⁃dose ultraviolet （UV） A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study［J］. Br J Dermatol, 2009,160（3）:652⁃658. doi: 10.1111/j.1365⁃2133.2008.08984.x.
［47］	Wollenberg A, Barbarot S, Bieber T, et al. Consensus⁃based European guidelines for treatment of atopic eczema （atopic dermatitis） in adults and children: part I［J］. J Eur Acad Dermatol Venereol, 2018,32（5）:657⁃682. doi: 10.1111/jdv.14891.
［48］	Majoie IM, Oldhoff JM, van Weelden H, et al. Narrowband ultraviolet B and medium⁃dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis［J］. J Am Acad Dermatol, 2009,60（1）:77⁃84. doi: 10.1016/j.jaad.2008.08.048.
［49］	Malinowska K, Woźniacka A, Bogaczewicz J. The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis［J］. Postepy Dermatol Alergol, 2020,37（6）:962⁃967. doi: 10.5114/ada.2019. 88465.
［50］	Park JB, Jang JY, Kwon DI, et al. The effectiveness of high⁃dose ultraviolet A⁃1 phototherapy for acute exacerbation of atopic dermatitis in Asians［J］. Photodermatol Photoimmunol Photomed, 2020,36（4）:263⁃270. doi: 10.1111/phpp.12546.
［51］	Zane C, Leali C, Airò P, et al. "High⁃dose" UVA1 therapy of widespread plaque⁃type, nodular, and erythrodermic mycosis fungoides［J］. J Am Acad Dermatol, 2001,44（4）:629⁃633. doi: 10.1067/mjd.2001.110896.
［52］	Polańska A, Osmola⁃Mańkowska A, Olek⁃Hrab K, et al. High⁃frequency ultrasonography in objective evaluation of the efficacy of PUVA and UVA 1 phototherapy in mycosis fungoides［J］. Arch Dermatol Res, 2017,309（8）:645⁃651. doi: 10.1007/s00403⁃017⁃1767⁃7.
［53］	Adışen E, Tektaş V, Erduran F, et al. Ultraviolet A1 phototherapy in the treatment of early mycosis fungoides［J］. Dermatology, 2017,233（2⁃3）:192⁃198. doi: 10.1159/000458149.
［54］	Zerbinati N, Portale S, Palmieri B, et al. A preliminary study to assess the efficacy of a new UVA1 laser for treatment of psoriasis［J］. Photomed Laser Surg, 2012,30（10）:610⁃614. doi: 10.1089/pho.2012.3281.
［55］	Silpa⁃Archa N, Pattanaprichakul P, Charoenpipatsin N, et al. The efficacy of UVA1 phototherapy in psoriasis: clinical and histological aspects［J］. Photodermatol Photoimmunol Photomed, 2020,36（1）:21⁃28. doi: 10.1111/phpp.12498.
［56］	高芸璐, 丁杨峰, 易雪梅. UVA1和窄波UVB光疗治疗斑块型银屑病的随机对照研究［J］. 中国中西医结合皮肤性病学杂志, 2018,17（2）:161⁃164. doi: 10.3969/j.issn.1672⁃0709.2018.02. 022.
［57］	El⁃Zawahry BM, Elmasry MF, Ragab A. The role of long⁃wavelength ultraviolet A1 （UVA1） in acral vitiligo［J］. J Cosmet Dermatol, 2019,18（4）:1155⁃1160. doi: 10.1111/jocd.12808.
［58］	El⁃Zawahry BM, Bassiouny DA, Sobhi RM, et al. A comparative study on efficacy of UVA1 vs. narrow⁃band UVB phototherapy in the treatment of vitiligo［J］. Photodermatol Photoimmunol Photomed, 2012,28（2）:84⁃90. doi: 10.1111/j.1600⁃0781.2011. 00643.x.
［59］	Rombold S, Lobisch K, Katzer K, et al. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases［J］. Photodermatol Photoimmunol Photomed, 2008,24（1）:19⁃23. doi: 10.1111/j.1600⁃0781.2008.00328.x.
［60］	Welsh O. Phototherapy for alopecia areata［J］. Clin Dermatol, 2016,34（5）:628⁃632. doi: 10.1016/j.clindermatol.2016.05.014.
［61］	Hofbauer G. Phototherapy and carcinogenesis［J］. Hautarzt, 2013,64（5）:349⁃353. doi: 10.1007/s00105⁃013⁃2587⁃0.

[1]	Wei Jin, Zang Dongjie, Zeng Sanwu, Jiang Jing, Lun Wenhui. Mutation analysis of the KRT5 gene in a Chinese pedigree with Dowling-Degos disease [J]. Chinese Journal of Dermatology, 2022, 55(8): 703-705.
[2]	Jin Liang, Liu Ling. Treatment of some genodermatoses [J]. Chinese Journal of Dermatology, 2022, 55(8): 735-739.
[3]	Xu Zhe. Some thoughts on hereditary dermatoses [J]. Chinese Journal of Dermatology, 2022, 55(8): 651-652.
[4]	Committee on Autoimmune Diseases, China Dermatologist Association. Cyclosporine in the treatment of immune-related skin diseases: an expert proposal [J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479.
[5]	Li Danqi, Lou Yuchen, Tao Juan. Application of high-dose intravenous immunoglobulin therapy in severe dermatoses [J]. Chinese Journal of Dermatology, 2022, 55(5): 455-459.
[6]	Shan Ying, Zuo Yagang. Correlation between autoimmune bullous diseases and psoriasis [J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455.
[7]	Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.
[8]	Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology. Expert consensus on clinical application of wet-wrap therapy for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 289-294.
[9]	Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2022） [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195.
[10]	Wang Jiaqi, Wang Ping, Li Liuyu, Fan Qimin, Zhu Mengyan, Wang Yanqing, Zhou Hongyu, Shen Hong, Xu Ai′e. Cutaneous hypopigmented lymphoproliferative disorders: a clinicopathological study of 41 cases [J]. Chinese Journal of Dermatology, 2022, 55(2): 110-115.
[11]	Lin Yuchieh, Liu Fengjie, Gao Yumei, Liu Xiangjun, Xu Bufang, Li Yingyi, Lai Pan, Chen Zhuojing, Sun Jingru, Tu Ping, Wang Yang. Significance of lysophosphatidic acid receptor 6 in the large-cell transformation of mycosis fungoides and its effect on the proliferation and apoptosis of cutaneous T-cell lymphoma cells [J]. Chinese Journal of Dermatology, 2022, 55(2): 102-109.
[12]	Zhang Guoyi, Gong Xiangdong, Zhu Bokun, Liu Chuanxia, Jing Linghua, Xu Jinyu. Patterns of skin diseases among outpatients attending Hospital of Dermatology of Chinese Academy of Medical Sciences in 2019 [J]. Chinese Journal of Dermatology, 2022, 55(2): 150-152.
[13]	Chinese Society of Dermatology, China Dermatologist Association, Chinese Association of Integrative Medicine Board of Dermatovenereology. Expert consensus on the clinical application of chemical peeling in China （2022） [J]. Chinese Journal of Dermatology, 2022, 55(11): 949-955.
[14]	Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis （2022） [J]. Chinese Journal of Dermatology, 2022, 55(11): 939-949.
[15]	Pan Haihao, Li Yingyi, Qin Yao, Wen Yujie, Lai Pan, Xiong Shan, Cao Mengzhou, Sun Jingru, Tu Ping, Wang Yang. Correlations between pruritus and CC chemokine ligand 17 in patients with mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(11): 969-975.

Clinical application of ultraviolet A1 in dermatology: an expert consensus statement （2022）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［61］

Related Articles 15

Metrics

Comments

Recommended 10